Sanofi-Aventis U.S. LLC
Drug manufacturer · manufacturer
Unclaimed listing
82
Drug products
7
Therapeutic areas
About
Sanofi-Aventis U.S. LLC is listed in the FDA National Drug Code Directory with 82 marketed products, of which 82 are prescription drugs. Dosage forms include INJECTION, TABLET, KIT, SOLUTION, POWDER. Portfolio includes DEA-scheduled controlled substances.
What Sanofi-Aventis U.S. LLC makes
14 of 82 productsInjectable & Infusion · 41Other · 16Diabetes & Metabolic · 14Biologics & Vaccines · 3Cardiovascular · 3Immunology & Inflammation · 3Anti-infective · 2
- MERILOGinsulin aspart-szjj
- MERILOGinsulin aspart-szjj
- TOUJEO Maxinsulin glargine
- Insulin glargine U-300insulin glargine
- TOUJEOinsulin glargine
- Lantus Solostarinsulin glargine
- Lantusinsulin glargine
- Insulin glargine U-300 Maxinsulin glargine
- Soliqua 100/33insulin glargine and lixisenatide
- Apidra SoloStarinsulin glulisine
- Apidrainsulin glulisine
- ADMELOGinsulin lispro
- ADMELOGinsulin lispro
- ADMELOGinsulin lispro
Get a price
This listing is unclaimed, so post your requirement and every verified pharmacy licensed in your state will bid.
Request a quoteContact
Email and website are not published in the public registries — they are added when the listing is claimed.
From the FDA NDC Directory, refreshed 2026-08-15.
Is this your business?
Claim the listing to publish your catalog, answer buyer enquiries and bid on sourcing requests.
Claim this listing